Quality of life, treatment impact and duration, and the importance of individualized therapy are at the center of ...

Novartis' strong drug pipeline and financials support an 11% annual return by 2027. Learn why NVS stock offers 33% return ...

Ryoncil ® was approved in December 2024 by the United States Food and Drug Administration (FDA) for steroid-refractory acute ...

The Independent Data Monitoring Committee met this week on February 10, 2025 to evaluate the unblinded safety Phase 2b QUALITY data and recommended to continue the QUALITY extension study as designed- ...

I have been diagnosed with prostate cancer. My wife knows about it and has been very supportive, but we have not shared it ...

Regenxbio's gene therapy faces market challenges as Goldman Sachs lowers its rating and price target, citing competition and ...

Send questions to R. Eric Thomas at eric@askingeric.com or P.O. Box 22474, Philadelphia, PA 19110. Follow him on Instagram ...

Pfizer terminated partnership with Sangamo on hemophilia A gene therapy despite positive Phase 3 data. Find out why SGMO ...

Nvidia stock rose on Monday amid mixed news from Taiwan Semiconductor. Nvidia will report its fourth quarter results on Feb.

Twenty-two-year-old Jessica buys Jellycats frequently and has built up a collection worth over £1,000, which she posts about ...

Glaukos Corporation GKOS is well-poised for growth on the back of favorable clinical trial results and a robust product ...